Smith & Nephew beginning shipments of Mosaic Plasty instruments for knee cartilage repair in July.
This article was originally published in The Gray Sheet
Executive SummarySMITH & NEPHEW MOSAIC PLASTY INSTRUMENT SYSTEM FOR KNEE CARTILAGE REPAIR will begin shipping July 1 in the U.S. following completion of product-specific training for Smith & Nephew Endoscopy's 200-rep sales force, the company says. An international launch is slated for August 1 through distributors. The "specially designed" instruments are designed to perform "autogenous osteochondral grafting," an articular cartilage knee repair technique for treating lesions resulting from sports injuries.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.